Drug Type Small molecule drug |
Synonyms LAMLIQUE |
Target |
Action blockers |
Mechanism Sodium channels blockers |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (25 Sep 2026), |
Regulation- |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Bipolar I disorder | United States | 25 Sep 2026 | |
| Epilepsies, Partial | United States | 25 Sep 2026 | |
| Epilepsy, Tonic-Clonic | United States | 25 Sep 2026 | |
| Lennox Gastaut Syndrome | United States | 25 Sep 2026 |





